Feb 3, 2026· Comment from National Association of Manufacturers· FDA-2025-N-4731-0049
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2025-N-4731
Increasing Availability of Nonprescription Drugs; Request for Information
RIN
—
Last modified
May 21, 2026
Comment window
closed 81d ago
National Association of Manufacturers (NAM) filings
1
Activity
National Association of Manufacturers (NAM) filed 1 comment on this docket between Feb 3, 2026 and Feb 3, 2026. 16 other organizations filed here. The comment window closed 81d ago.
What National Association of Manufacturers (NAM) filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (16)
See everyone who commented →- National Association of Manufacturers (NAM)THIS ORG1 filing · confidence 97%
- American Pharmacists Association (APhA)trade assoc.2 filings · confidence 97%
- Consumer Healthcare Products Associationtrade assoc.2 filings · confidence 97%
- National Association of Chain Drug Storestrade assoc.2 filings · confidence 97%
- Alliance for Aging Researchtrade assoc.1 filing · confidence 85%
- Alliance for Women's Health & Preventiontrade assoc.1 filing · confidence 85%
- American Academy of Dermatology Associationtrade assoc.1 filing · confidence 85%
- American Association of Nurse Practitionerstrade assoc.1 filing · confidence 85%
- American Heart Associationtrade assoc.1 filing · confidence 85%
- American Lung Associationtrade assoc.1 filing · confidence 85%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- Cohen Nonprescription Consulting LLCunverified attribution1 filing · confidence 70%
- CPAC Foundation Center for Regulatory Freedomtrade assoc.1 filing · confidence 85%
- National Community Pharmacists Associationtrade assoc.1 filing · confidence 97%
- National Council for Prescription Drug Programs - NCPDPtrade assoc.1 filing · confidence 85%
- Taxpayers Protection Alliancetrade assoc.1 filing · confidence 85%
- U.S. Chamber of Commerce1 filing · confidence 97%